Stocks › EXEL
EXELIXIS, INC.
EXEL·Nasdaq·
United States·USD
United States·USD$58.33
-0.52 (-0.88%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
EXEL
EXELIXIS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EXELS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EXEL by members of U.S. Congress · 6 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Ro KhannaHouse · D · CA |
EXELEXELIXIS, INC. · Stock |
Sale $1,001 - $15,000 |
Feb 5, 2024 | Jan 10, 2024 | Filing ↗ |
| Ro KhannaHouse · D · CA |
EXELEXELIXIS, INC. · Common Stock |
Purchase $1,001 - $15,000 |
Jan 6, 2023 | Dec 6, 2022 | Filing ↗ |
 Donna ShalalaHouse · D · FL |
EXELEXELIXIS, INC. · Stock |
Sale $1,001 - $15,000 |
Apr 27, 2020 | Jun 4, 2019 | Filing ↗ |
| Donna ShalalaHouse · D · FL |
EXELEXELIXIS, INC. · Stock |
Sale $1,001 - $15,000 |
Apr 27, 2020 | Apr 16, 2019 | Filing ↗ |
| Donna ShalalaHouse · D · FL |
EXELEXELIXIS, INC. · Stock |
Purchase $1,001 - $15,000 |
Apr 27, 2020 | Feb 6, 2019 | Filing ↗ |
| Donna ShalalaHouse · D · FL |
EXELEXELIXIS, INC. · Stock |
Purchase $1,001 - $15,000 |
Apr 27, 2020 | Jan 9, 2019 | Filing ↗ |
Whale Activity
Position changes in EXEL reported for 2026-06-30 by 15 tracked institutional filers
- Increased3
- New0
- Held0
- Decreased6
- Closed0
- No prior filing6
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 29.1M | $1.58B | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 13.4M | $730.6M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12.0M | $655.3M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.0M | $595.8M | decreased |
| FULLER & THALER ASSET MANAGEMENT, INC. | 8.9M | $485.8M | — |
| D. E. Shaw & Co., Inc. | 5.6M | $302.1M | increased |
| TWO SIGMA INVESTMENTS, LP | 4.2M | $229.1M | increased |
| Stephens Investment Management Group LLC | 2.7M | $147.5M | — |
| MILLENNIUM MANAGEMENT LLC | 1.2M | $66.3M | increased |
| Bridgewater Associates, LP | 400.9K | $21.8M | decreased |
| GLOBEFLEX CAPITAL L P | 255.0K | $13.9M | — |
| L2 Asset Management, LLC | 125.7K | $6.8M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EXEL insiders, by quarter · Form 4
Recent Insider Transactions
3,429 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Beckerle Mary CDirector · Director | Sale | −9,812 | $53.66 | $527K | Aug 10, 2026 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −3,925 | $50.55 | $198K | Jun 1, 2026 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −9,812 | $50.14 | $492K | Jun 1, 2026 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Heyman Tomas J.Director | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Smith JulieDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Freire Maria CDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Beckerle Mary CDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Oliver BobDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| POSTE GEORGEDirector | Grant / award | +8,367 | $0.00 | $0 | May 27, 2026 | Form 4 ↗ |
| Aftab DanaEVP, Research and Development | Sale | −43.5K | $50.35 | $2.2M | May 26, 2026 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −32.1K | $49.81 | $1.6M | May 20, 2026 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Gift | +124.0K | $0.00 | $0 | May 18, 2026 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Gift | −124.0K | $0.00 | $0 | May 18, 2026 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −34.9K | $50.00 | $1.7M | May 18, 2026 | Form 4 ↗ |
| Hefti BrendaSVP and General Counsel | Sale | −6,625 | $50.21 | $333K | May 18, 2026 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Tax withholding | −128.5K | $51.10 | $6.6M | May 15, 2026 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Tax withholding | −40.9K | $51.10 | $2.1M | May 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EXEL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 8.6M | $468.0M | 0.38% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 7.6M | $412.6M | 0.02% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust | 7.0M | $383.1M | 3.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 5.5M | $297.8M | 0.16% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 3.2M | $171.7M | 0.37% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.9M | $156.8M | 0.16% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF Invesco Exchange-Traded Fund Trust | 2.8M | $147.1M | 2.70% | Jul 31, 2026 |
| State Street SPDR S&P MidCap 400SM ETF Trust SPDR S&P MIDCAP 400 ETF TRUST | 1.9M | $105.2M | 0.38% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.9M | $103.0M | 0.96% | Jun 30, 2026 |
| iShares Biotechnology ETF iShares Trust | 1.7M | $93.9M | 1.03% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list EXEL's shares (CUSIP 30161Q104), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Farallon Capital F5 Master I, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Farallon Capital (AM) Investors, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Farallon Capital Offshore Investors II, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Four Crossings Institutional Partners V, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Farallon Capital Institutional Partners III, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Farallon Capital Institutional Partners II, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Farallon Capital Institutional Partners, L.P.SCHEDULE 13D/A · activist (13D) · 0 shares0.0%
Aug 14, 2026 · ↗ - Wehrly, Mark C.SCHEDULE 13D/A · activist (13D) · 14.0M shares5.6%
Aug 14, 2026 · ↗ - Warren, John R.SCHEDULE 13D/A · activist (13D) · 14.0M shares5.6%
Aug 14, 2026 · ↗ - Spokes, Andrew J. M.SCHEDULE 13D/A · activist (13D) · 14.0M shares5.6%
Aug 14, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming exelixis as client
- TODD STRATEGY GROUPEXELIXIS, INC. · 2026 Q2 · HCR, MMM, CPT$50K
Filing ↗ - EXELIXIS INC.EXELIXIS INC. · 2026 Q2 · HCR, TAX$560K
Filing ↗ - ARNOLD & PORTER KAYE SCHOLER LLPEXELIXIS, INC. · 2026 Q2 · HCR, MMM$60K
Filing ↗ - W STRATEGIES, LLCEXELIXIS, INC. · 2026 Q2 · MMM$60K
Filing ↗ - THORN RUN PARTNERSEXELIXIS · 2026 Q2 · MMM, HCR$60K
Filing ↗
Government Contracts
Federal awards to EXELIXIS, INC. · USAspending
No federal contract awards found for EXELIXIS, INC..
U.S. Patents
Recent USPTO applications naming EXELIXIS, INC.
No USPTO patent applications found for EXELIXIS, INC..
Annual Financials
From EXEL's 10-K filings · XBRL
No annual XBRL figures on record for EXEL. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in EXEL's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01Other eventsSep 11, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsAug 31, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 29, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 5, 2026
EDGAR ↗
About EXELIXIS, INC.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersALAMEDA, CA
IncorporatedDE
SEC CIK0000939767 ↗
Former namesEXELIXIS INC